Location History:
- Roscommon, IR (2005)
- Co Roscommon, IE (2010)
- Co. Roscommon, IE (2010)
- Athlone, IE (2001 - 2015)
- Roscommon, IE (2005 - 2015)
Company Filing History:
Years Active: 2001-2015
Title: The Innovative Contributions of John G Devane
Introduction
John G Devane is a notable inventor based in Athlone, Ireland, recognized for his substantial contributions to the field of pharmaceuticals. With a total of 15 patents to his name, his work focuses primarily on methods and formulations that benefit gastrointestinal health and lipid management.
Latest Patents
Among his most recent inventions are significant advancements that include:
1. **Methods and compositions comprising at least one α3 βA4 nAChR antagonist or pharmaceutically acceptable salt thereof**. This invention is aimed at improving methods and formulations for treating gastrointestinal secretion and related intestinal conditions.
2. **Pharmaceutical formulations for carrier-mediated transport statins and uses thereof**. This invention focuses on creating formulations that contain acid-stable, carrier-mediated transport statins like atorvastatin and rosuvastatin, allowing for controlled release in the small intestine. These techniques are particularly beneficial for managing cholesterol and lipid levels in the body.
Career Highlights
John has had a distinguished career, significantly contributing to the pharmaceutical industry. He has worked with prominent companies such as Elan Corporation and Agi Therapeutics Ltd., where he has further developed his expertise in creating innovative therapeutic solutions.
Collaborations
Throughout his career, John has worked alongside notable professionals in the field, including Paul Stark and Jackie Butler. Their collaboration has fostered a dynamic environment for innovation and has led to the development of various effective pharmaceutical solutions.
Conclusion
John G Devane's illustrious journey in innovation illustrates the vital role of inventors in advancing healthcare solutions. With a focus on improving pharmaceutical formulations and effectively managing health conditions, his contributions continue to make a significant impact within the industry.